Rapid elimination of cervical cancer while maintaining the harms and benefits ratio of cervical cancer screening: a modelling study

Human papillomavirus (HPV) vaccination and intensifying screening expedite cervical cancer (CC) elimination, yet also deteriorate the balance between harms and benefits of screening. We aimed to find screening strategies that eliminate CC rapidly but maintain an acceptable harms-benefits ratio of sc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Jansen, Erik (VerfasserIn) , de Kok, Inge M. C. M. (VerfasserIn) , Kaljouw, Sylvia (VerfasserIn) , Demirel, Erhan (VerfasserIn) , de Koning, Harry J. (VerfasserIn) , Hontelez, Jan (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 09 November 2022
In: BMC medicine
Year: 2022, Jahrgang: 20, Pages: 1-10
ISSN:1741-7015
DOI:10.1186/s12916-022-02631-7
Online-Zugang:Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1186/s12916-022-02631-7
Verlag, lizenzpflichtig, Volltext: https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-022-02631-7
Volltext
Verfasserangaben:Erik E.L. Jansen, Inge M.C.M. de Kok, Sylvia Kaljouw, Erhan Demirel, Harry J. de Koning and Jan. A.C. Hontelez
Beschreibung
Zusammenfassung:Human papillomavirus (HPV) vaccination and intensifying screening expedite cervical cancer (CC) elimination, yet also deteriorate the balance between harms and benefits of screening. We aimed to find screening strategies that eliminate CC rapidly but maintain an acceptable harms-benefits ratio of screening.
Beschreibung:Gesehen am 24.01.2023
Beschreibung:Online Resource
ISSN:1741-7015
DOI:10.1186/s12916-022-02631-7